fluticasone propionate controlled release (EP-104) / Syreon, Eupraxia Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fluticasone propionate controlled release (EP-104) / Eupraxia Pharma
STEPUP, NCT02609126: Safety Study of a Long-Acting Injectable Steroid to Treat Knee Osteoarthritis

Completed
1
32
Canada
EP-104IAR, Vehicle
Eupraxia Pharmaceuticals Inc., Syreon Corporation
Osteoarthritis, Knee
12/17
12/17

Download Options